Literature DB >> 4564399

Effect of an interferon stimulator, polyinosinic: polycytidylic acid, on experimental fungus infections.

M Worthington, H F Hasenclever.   

Abstract

IN THE PRESENT STUDY, THE ADMINISTRATION OF AN INTERFERON STIMULATOR, POLYINOSINIC: polycytidylic acid (In:Cn), increased the severity of both experimental Candida albicans and Coccidioides immitis infections in mice, as evidenced by earlier time of death and higher final mortality. In addition, kidney tissue levels of C. albicans at 3 and 5 days after infection were found to be about 40- to 300-fold higher in In:Cn treated mice than in control mice. Experimental Cryptococcus neoformans infection, however, was not significantly affected by In:Cn treatment.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564399      PMCID: PMC422348          DOI: 10.1128/iai.5.2.199-202.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  8 in total

1.  Interferon: protection of cells infected with an intracellular protozoan (Toxoplasma gondii).

Authors:  J S Remington; T C Merigan
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

2.  Induction of resistance to bacterial infections of mice with poly I-poly C.

Authors:  M J Weinstein; J A Waitz; P E Came
Journal:  Nature       Date:  1970-04-11       Impact factor: 49.962

3.  Protective effect of interferon inducers on Plasmodium berghei malaria.

Authors:  R I Jahiel; R S Nussenzweig; J Vilcek; J Vanderberg
Journal:  Am J Trop Med Hyg       Date:  1969-11       Impact factor: 2.345

4.  Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.

Authors:  A K Field; A A Tytell; G P Lampson; M R Hilleman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

5.  Fungal infections complicating acute leukemia.

Authors:  G P Bodey
Journal:  J Chronic Dis       Date:  1966-06

6.  Effect of the interferon stimulator polyinosinic-polycytidylic acid on experimental Trypanosoma cruzi infection.

Authors:  R Kumar; M Worthington; J G Tilles; W H Abelmann
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

7.  Effects of poly I-C on the course of infection with Trypanosoma cruzi.

Authors:  R Martinez-Silva; V A Lopez; J Chiriboga
Journal:  Proc Soc Exp Biol Med       Date:  1970-07

8.  THE ROLE OF THE THYMUS IN RESISTANCE TO INFECTION AND ENDOTOXIN TOXICITY.

Authors:  S B SALVIN; R D PETERSON; R A GOOD
Journal:  J Lab Clin Med       Date:  1965-06
  8 in total
  7 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  Gamma interferon is not essential in host defense against disseminated candidiasis in mice.

Authors:  Q Qian; J E Cutler
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

3.  Increased toxicity of double-stranded ribonucleic acid in virus-infected animals.

Authors:  E De Clercq; W E Stewart; P De Somer
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

4.  Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.

Authors:  J Jensen; A Vazquez-Torres; E Balish
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

5.  In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.

Authors:  R E Garner; U Kuruganti; C W Czarniecki; H H Chiu; J E Domer
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

6.  Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.

Authors:  Edward Sionov; Katrin D Mayer-Barber; Yun C Chang; Keith D Kauffman; Michael A Eckhaus; Andres M Salazar; Daniel L Barber; Kyung J Kwon-Chung
Journal:  PLoS Pathog       Date:  2015-08-07       Impact factor: 6.823

Review 7.  Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection.

Authors:  R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Front Cell Infect Microbiol       Date:  2013-11-12       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.